These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8241005)

  • 1. Cyproterone acetate: hepatotoxicity and prostatic cancer treatment.
    Roila F; Crinò L; Carloni G; Natalini G
    Ann Oncol; 1993 Sep; 4(8):701. PubMed ID: 8241005
    [No Abstract]   [Full Text] [Related]  

  • 2. Suspected cross-hepatotoxicity of flutamide and cyproterone acetate.
    Miquel M; Soler A; Vaqué A; Ojanguren I; Costa J; Planas R
    Liver Int; 2007 Oct; 27(8):1144-7. PubMed ID: 17845544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute hepatitis induced by cyproterone acetate.
    Giordano N; Nardi P; Santacroce C; Geraci S; Gennari C
    Ann Pharmacother; 2001 Sep; 35(9):1053-5. PubMed ID: 11573856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal fulminant hepatic failure due to cyproterone acetate.
    Friedman G; Lamoureux E; Sherker AH
    Dig Dis Sci; 1999 Jul; 44(7):1362-3. PubMed ID: 10489919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal acute liver failure induced by cyproterone acetate: A new case.
    Nour E; Mehdi K; Hanene J; Hammami A; Ben Slama A; Ali J
    Presse Med; 2017 Dec; 46(12 Pt 1):1231-1232. PubMed ID: 29129412
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe hepatitis and liver failure induced by cyproterone acetate.
    Murphy BJ; Collins BJ
    Aust N Z J Med; 1996 Oct; 26(5):724. PubMed ID: 8958378
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe hepatitis caused by cyproterone acetate.
    Blake JC; Sawyerr AM; Dooley JS; Scheuer PJ; McIntyre N
    Gut; 1990 May; 31(5):556-7. PubMed ID: 2140997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute hepatic necrosis in a patient treated with cyproterone acetate].
    Lombardi A; Ferrazza P; Castaldi F; Covotta L; Tesoriere A; Urbano V; Midiri G
    G Chir; 1998 Apr; 19(4):161-3. PubMed ID: 9628065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe hepatitis induced by cyproterone acetate: role of corticosteroids. A case report.
    Abenavoli L; Milic N; Beaugrand M
    Ann Hepatol; 2013; 12(1):152-5. PubMed ID: 23293208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe hepatocellular dysfunction following cyproterone acetate therapy.
    Parys BT; Hamid S; Thomson RG
    Br J Urol; 1991 Mar; 67(3):312-3. PubMed ID: 1827039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fatal subfulminant hepatitis caused by cyproterone acetate].
    Antoni M; Bourlière M; Toullec J; Maillot A; Botta-Fridlund D; Gauthier A
    Gastroenterol Clin Biol; 1991; 15(10):772-3. PubMed ID: 1840042
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fatal hepatitis caused by cyproterone acetate].
    Bressollette L; Dubois A; Carlhant D; Morand C; Mottier D; Riche C
    Therapie; 1994; 49(2):153. PubMed ID: 7817350
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyproterone acetate induces a wide spectrum of acute liver damage including corticosteroid-responsive hepatitis: report of 22 cases.
    Bessone F; Lucena MI; Roma MG; Stephens C; Medina-Cáliz I; Frider B; Tsariktsian G; Hernández N; Bruguera M; Gualano G; Fassio E; Montero J; Reggiardo MV; Ferretti S; Colombato L; Tanno F; Ferrer J; Zeno L; Tanno H; Andrade RJ
    Liver Int; 2016 Feb; 36(2):302-10. PubMed ID: 26104271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiandrogen-associated hepatotoxicity in the management of advanced prostate cancer.
    Lin AD; Chen KK; Lin AT; Chang YH; Wu HH; Kuo JY; Huang WJ; Hsu YS; Chung HJ; Chang LS
    J Chin Med Assoc; 2003 Dec; 66(12):735-40. PubMed ID: 15015823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic hepatitis after sequential administration of flutamide and cyproterone acetate.
    Manolakopoulos S; Bethanis S; Armonis A; Economou M; Avgerinos A; Tzourmakliotis D
    Dig Dis Sci; 2004 Mar; 49(3):462-5. PubMed ID: 15139499
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatotoxicity induced by cyproterone acetate: a report of three cases.
    Savidou I; Deutsch M; Soultati AS; Koudouras D; Kafiri G; Dourakis SP
    World J Gastroenterol; 2006 Dec; 12(46):7551-5. PubMed ID: 17167851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyproterone-induced hepatotoxicity.
    Pinganaud G; Chaslerie A; Bourdel Marchasson I; Decamps A; Manciet G; Emeriau JP
    Ann Pharmacother; 1995 Jun; 29(6):634. PubMed ID: 7663042
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiandrogen withdrawal syndrome with cyproterone acetate.
    Sella A; Flex D; Sulkes A; Baniel J
    Urology; 1998 Dec; 52(6):1091-3. PubMed ID: 9836560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyproterone acetate in the treatment of advanced prostatic cancer: retrospective analysis of liver toxicity in the long-term follow-up of 89 patients.
    Hinkel A; Berges RR; Pannek J; Schulze H; Senge T
    Eur Urol; 1996; 30(4):464-70. PubMed ID: 8977068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatitis after treatment with cyproterone acetate. Apropos of a case].
    Dore B; Orget J; Irani J; Aubert J
    J Urol (Paris); 1990; 96(3):169-71. PubMed ID: 2145371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.